At the crossroads of pandemic-era medicine and cancer care, Yorkshire Cancer Research has opened a 2026 funding round inviting clinicians to ask whether the mRNA vaccines that reshaped public health might also strengthen the immune system's capacity to fight cancer. The initiative responds to early, unconfirmed signals from clinical observation — patients on immunotherapy who were vaccinated against COVID-19 appearing to respond more robustly to treatment. With applications due October 15 and decisions expected in December, the effort reflects a broader reckoning in oncology: that tools develo